Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

$833K USD

Funder	National Institutes of Health
Recipient Organization	Not specified
Country	USA
Start Date	Nov 18, 2024
End Date	Mar 07, 2027
Duration	839 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`44c6e7ba-1c3f-4a79-8cf1-6116a1ae062a`

Grant Description

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD).

The findings are expected to advanceadavnce mechanistic understanding of both biobehavioral and neurobiologfical pathways leading to NPS.

Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD.